Reprogrammed metabolism of cancer cells as a potential therapeutic target

Jaap Keijer, Dorien A M van Dartel1

  • 1Human and Animal Physiology, Wageningen University, De Elst 1, PO box 338, 6700 AH Wageningen, The Netherlands. jaap.keijer@wur.nl.

Insights

Cancer cells reprogram their metabolism, relying on glycolysis for energy and growth. Targeting this altered cancer metabolism offers new therapeutic strategies, including nutritional interventions.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolic Pathways

Background:

  • Cancer cells exhibit significant metabolic reprogramming compared to normal cells.
  • This metabolic shift supports uncontrolled proliferation, survival, and resistance to apoptosis.
  • Altered cancer metabolism is a recognized hallmark of cancer, driving tumor progression.

Purpose of the Study:

  • To review the metabolic reprogramming characteristic of cancer cells.
  • To elucidate the relationship between metabolic alterations, cell cycle progression, and apoptosis resistance.
  • To explore therapeutic strategies targeting cancer metabolism, including nutritional interventions.

Main Methods:

  • Literature review of metabolic reprogramming in cancer.
  • Analysis of the link between cancer metabolism, cell cycle, and apoptosis.
  • Identification of therapeutic targets and nutritional intervention strategies.

Main Results:

  • Cancer cells predominantly utilize glycolysis for ATP production.
  • Metabolic alterations enable biosynthesis of essential components for cell growth.
  • Reprogrammed metabolism contributes to resistance to programmed cell death (apoptosis).

Conclusions:

  • Targeting cancer cell metabolism presents a promising therapeutic avenue.
  • Nutritional strategies and bioactive food components can be leveraged for cancer treatment.
  • Understanding metabolic reprogramming is crucial for developing effective cancer therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...